57683-62-2Relevant academic research and scientific papers
HYDROXYNORKETAMINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS
-
Paragraph 0271, (2018/03/25)
Chemical entities of Formula (I): Including enantiomers thereof, wherein R1 has any of the values described herein, and compositions comprising such chemical entities; their preparation; and their use in various methods, including the treatment of depression, pain, cognitive disorders, neurodegenerative disorders, and other neurological and peripheral disorders.
Antimicrobial, antioxidant and cytotoxic effect of Molybdenum trioxide nanoparticles and application of this for degradation of ketamine under different light illumination
Fakhri, Ali,Nejad, Pedram Afshar
, p. 211 - 217 (2016/04/20)
A hydrothermal method was employed to synthesize Molybdenum trioxide (MoO3) nanoparticles. The synthesized samples were evaluated for photocatalytic properties and biological application. The nanoparticles characterized by scanning electron microscopy, powder X-ray diffraction, transmission electron microscopy, an energy dispersive X-ray spectrometer and UV-Vis DRS spectra. The synthesized MoO3 NPs were found to be spherical in shape with size in the range of 75 nm. The synthesized MoO3 nanoparticles have good optical properties with 2.78 eV of band-gap. The photocatalytic properties of the synthesized MoO3 nanoparticles were carried out by performing the degradation of ketamine under visible, UV and sunlight irradiations. A high efficiency was observed between sunlight and MoO3 nanoparticles for the photocatalysis reaction. Two compounds as intermediates of photo-degradation of ketamine under visible and UV lights were detected. The antifungal activity of the nanoscale MoO3 against Candida albicans and Aspergillus niger was assessed using the disc-diffusion susceptibility tests. All MoO3 nanoparticles concentrations showed good ABT radical scavenging activity. Then, this research has been presented to exhibit the synthesized MoO3 NPs which indicated a high antibacterial activity against Gram negative and positive bacteria and were also proved to exhibit excellent cytotoxic influence on lung and breast cancer cell lines. The results show that the high applicability of MoO3 nanoparticles biologically was great and is environmentally friendly.
Ketamine metabolism: Identification and synthesis of a deaminated product
Lai,Hong,Davisson
, p. 486 - 488 (2007/10/02)
During attempts to synthesize 2-amino-2-(2-chlorophenyl)-6-hydroxycyclohexanone (6), a ketamine metabolite, an unexpected product, 3-(2-chlorophenyl)-2-hydroxy-2-cyclohexenone (4) was obtained as the major product. This compound apparently was formed by rearrangement and deamination of 6 during the isolation and purification procedures. This same compound was found in plasma and urine extracts obtained from mice and rats that had been treated with either ketamine or norketamine. It is suggested that 3-(2-chlorophenyl)-2-hydroxy-2-cyclohexenone (4), isolated from these biological samples, probably arose from decomposition of the 6-hydroxylated metabolite of ketamine or norketamine and is itself not a true metabolite.
Synthesis of Ketamine Metabolites I and II and Some Anomalous Reactions of 6-Bromoketamine
Parcell, Robert F.,Sanchez, Joseph P.
, p. 5055 - 5060 (2007/10/02)
Two metabolites of the drug ketamine, 2-(2-chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride (1), have been synthesized.They are the N-demethyl compound, metabolite I (13), and the N-demethyl-5,6-dehydro analogue, metabolite II (15).Three bromo ketone derived from ketamine have also been synthesized and their realtive configuration assigned.In addition, attempted dehydrohalogenation of axial 2-bromoketamine (2a) with sodium amide in liquid ammonia has produced a novel entry into the 6-azabicycloheptane ring system.The structure of the rearrangement product (3) has been confirmed by unequivocal synthesis.Other unusual reactions include the reduction of an N-alkylazetidinone to an N-alkylazetidine and an acid-catalyzed N-alkyl cleavage of a β-lactam.
